Sonendo Inc (SONX)
0.1049
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Sonendo Research and Development Expense (Quarterly): 2.514M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.514M |
| September 30, 2023 | 3.049M |
| June 30, 2023 | 3.298M |
| March 31, 2023 | 3.494M |
| December 31, 2022 | 3.58M |
| September 30, 2022 | 4.328M |
| June 30, 2022 | 4.018M |
| Date | Value |
|---|---|
| March 31, 2022 | 4.85M |
| December 31, 2021 | 4.258M |
| September 30, 2021 | 4.633M |
| June 30, 2021 | 4.631M |
| March 31, 2021 | 5.046M |
| December 31, 2020 | 5.91M |
| September 30, 2020 | 4.92M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
2.514M
Minimum
Dec 2023
5.91M
Maximum
Dec 2020
4.181M
Average
4.293M
Median
Research and Development Expense (Quarterly) Benchmarks
| Dentsply Sirona Inc | 42.00M |
| Biolase Inc | 1.652M |
| Milestone Scientific Inc | 0.1769M |
| Wellness Center USA Inc | -- |
| Envista Holdings Corp | 23.30M |